Question is not whether they have canchew, question is what's the share structure, are they in clinical trial? AX!n has the backing of $$ from you know who. As well as the patent, and is in clinical trial.
I hear what the person is saying who posted the goal here may not be a big pharma break out and that's a good thing, but if one company gets the fda approval for cbd then what will become of these companies that are specializing in cbd nutracueticals?
News 
Market Data 
Discover 
